Cargando…
Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime
11H-Indeno[1,2-b]quinoxalin-11-one oxime (IQ-1) and tryptanthrin-6-oxime are potent c-Jun N-terminal kinase 3 (JNK-3) inhibitors demonstrating neuroprotective, anti-inflammatory and anti-arthritic activity. However, the stereochemical configuration of the oxime carbon–nitrogen double bond (E- or Z-)...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383563/ https://www.ncbi.nlm.nih.gov/pubmed/37513989 http://dx.doi.org/10.3390/pharmaceutics15071802 |
_version_ | 1785080941233831936 |
---|---|
author | Matveevskaya, Vladislava V. Pavlov, Dmitry I. Kovrizhina, Anastasia R. Sukhikh, Taisiya S. Sadykov, Evgeniy H. Dorovatovskii, Pavel V. Lazarenko, Vladimir A. Khlebnikov, Andrei I. Potapov, Andrei S. |
author_facet | Matveevskaya, Vladislava V. Pavlov, Dmitry I. Kovrizhina, Anastasia R. Sukhikh, Taisiya S. Sadykov, Evgeniy H. Dorovatovskii, Pavel V. Lazarenko, Vladimir A. Khlebnikov, Andrei I. Potapov, Andrei S. |
author_sort | Matveevskaya, Vladislava V. |
collection | PubMed |
description | 11H-Indeno[1,2-b]quinoxalin-11-one oxime (IQ-1) and tryptanthrin-6-oxime are potent c-Jun N-terminal kinase 3 (JNK-3) inhibitors demonstrating neuroprotective, anti-inflammatory and anti-arthritic activity. However, the stereochemical configuration of the oxime carbon–nitrogen double bond (E- or Z-) in these compounds was so far unknown. In this contribution, we report the results of the determination of the double bond configuration in the solid state by single crystal X-ray diffraction and in solution by 1D and 2D NMR techniques and DFT calculations. It was found that both in the solid state and in solution, IQ-1 adopts the E-configuration stabilized by intermolecular hydrogen bonds, in contrast to previously assumed Z-configuration that could be stabilized only by an intramolecular hydrogen bond. |
format | Online Article Text |
id | pubmed-10383563 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103835632023-07-30 Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime Matveevskaya, Vladislava V. Pavlov, Dmitry I. Kovrizhina, Anastasia R. Sukhikh, Taisiya S. Sadykov, Evgeniy H. Dorovatovskii, Pavel V. Lazarenko, Vladimir A. Khlebnikov, Andrei I. Potapov, Andrei S. Pharmaceutics Article 11H-Indeno[1,2-b]quinoxalin-11-one oxime (IQ-1) and tryptanthrin-6-oxime are potent c-Jun N-terminal kinase 3 (JNK-3) inhibitors demonstrating neuroprotective, anti-inflammatory and anti-arthritic activity. However, the stereochemical configuration of the oxime carbon–nitrogen double bond (E- or Z-) in these compounds was so far unknown. In this contribution, we report the results of the determination of the double bond configuration in the solid state by single crystal X-ray diffraction and in solution by 1D and 2D NMR techniques and DFT calculations. It was found that both in the solid state and in solution, IQ-1 adopts the E-configuration stabilized by intermolecular hydrogen bonds, in contrast to previously assumed Z-configuration that could be stabilized only by an intramolecular hydrogen bond. MDPI 2023-06-23 /pmc/articles/PMC10383563/ /pubmed/37513989 http://dx.doi.org/10.3390/pharmaceutics15071802 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Matveevskaya, Vladislava V. Pavlov, Dmitry I. Kovrizhina, Anastasia R. Sukhikh, Taisiya S. Sadykov, Evgeniy H. Dorovatovskii, Pavel V. Lazarenko, Vladimir A. Khlebnikov, Andrei I. Potapov, Andrei S. Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime |
title | Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime |
title_full | Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime |
title_fullStr | Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime |
title_full_unstemmed | Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime |
title_short | Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime |
title_sort | experimental and computational investigation of the oxime bond stereochemistry in c-jun n-terminal kinase 3 inhibitors 11h-indeno[1,2-b]quinoxalin-11-one oxime and tryptanthrin-6-oxime |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383563/ https://www.ncbi.nlm.nih.gov/pubmed/37513989 http://dx.doi.org/10.3390/pharmaceutics15071802 |
work_keys_str_mv | AT matveevskayavladislavav experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime AT pavlovdmitryi experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime AT kovrizhinaanastasiar experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime AT sukhikhtaisiyas experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime AT sadykovevgeniyh experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime AT dorovatovskiipavelv experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime AT lazarenkovladimira experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime AT khlebnikovandreii experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime AT potapovandreis experimentalandcomputationalinvestigationoftheoximebondstereochemistryincjunnterminalkinase3inhibitors11hindeno12bquinoxalin11oneoximeandtryptanthrin6oxime |